AJR Your Link to CME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harvey, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harvey, J. A.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

American Journal of Roentgenology, Vol 172, 1615-1619, Copyright © 1999 by American Roentgen Ray Society

ARTICLES

Use and cost of breast imaging for postmenopausal women undergoing hormone replacement therapy

JA Harvey
Department of Radiology, University of Virginia, Charlottesville 22908, USA.

OBJECTIVE: The purpose of this study was to evaluate the use and associated costs of breast imaging studies for postmenopausal women undergoing hormone replacement therapy (HRT). MATERIALS AND METHODS: Clinical findings, mammographic findings, and imaging studies performed on 1133 postmenopausal women during a 5-month period in 1996 were retrospectively reviewed. Cost was estimated using Medicare reimbursement rates. RESULTS: Of the 1133 women, 699 (62%) underwent HRT. The number of women with breast complaints was similar for those undergoing (n = 62, 9%) and not undergoing (n = 26, 6%) HRT. Benign findings were more common for women undergoing HRT (n = 186, 27%) than for women not undergoing HRT (n = 92, 21%) (p = .04). Masses were noted in 133 of the women undergoing HRT (19%), compared with 42 women not undergoing HRT (10%) (p < .000). Specifically, cysts were seen in 46 women undergoing HRT (7%), compared with five women not undergoing HRT (1%) (p < .0001). Diagnostic mammograms and sonograms were more commonly obtained in women undergoing HRT (33 and 13 per 100 women, respectively) than in women not undergoing HRT (24 and seven per 100, respectively) (p = .014 and .0007, respectively). The overall cost of breast imaging was $89 for each woman undergoing HRT and $87 for each woman not undergoing HRT. CONCLUSION: Benign mammographic findings, primarily cysts, in women undergoing HRT result in an increased use of diagnostic mammography and sonography. The minimal increase in cost should not be a significant factor in the decision to use HRT.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
A. M. Kavanagh, J. Cawson, G. B. Byrnes, G. G. Giles, G. Marr, B. Tong, D. M. Gertig, and J. L. Hopper
Hormone Replacement Therapy, Percent Mammographic Density, and Sensitivity of Mammography
Cancer Epidemiol. Biomarkers Prev., May 1, 2005; 14(5): 1060 - 1064.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Roentgen Ray Society.